NewsBlazeAU – Lifestyle
Author:
AlzeCure Pharma
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 13, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 13, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 5, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
April 30, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 30, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 26, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
April 20, 2026
AlzeCure Pharma Publishes its Annual Report for 2025
April 8, 2026
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
April 7, 2026
1
2
Next Page
→